APA
Jeyakumar G., Kim S., Bumma N., Landry C., Silski C., Suisham S., Dickow B., Heath E., Fontana J. & Vaishampayan U. (20180626). Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy. : Journal for immunotherapy of cancer.
Chicago
Jeyakumar Ghayathri, Kim Seongho, Bumma Naresh, Landry Craig, Silski Cynthia, Suisham Stacey, Dickow Brenda, Heath Elisabeth, Fontana Joseph and Vaishampayan Ulka. 20180626. Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy. : Journal for immunotherapy of cancer.
Harvard
Jeyakumar G., Kim S., Bumma N., Landry C., Silski C., Suisham S., Dickow B., Heath E., Fontana J. and Vaishampayan U. (20180626). Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy. : Journal for immunotherapy of cancer.
MLA
Jeyakumar Ghayathri, Kim Seongho, Bumma Naresh, Landry Craig, Silski Cynthia, Suisham Stacey, Dickow Brenda, Heath Elisabeth, Fontana Joseph and Vaishampayan Ulka. Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy. : Journal for immunotherapy of cancer. 20180626.